FdaApplication
BLA 761024
Identifiers
- fda_app_no: BLA761024
Properties
| Property | Value |
|---|---|
| applicant_name | Amgen Inc. |
| application_type | BLA |
| approval_date | 2016-09-23 |
Products (9)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMJEVITA | ADALIMUMAB-ATTO | 20MG/0.4ML | Injection |
| AMJEVITA | ADALIMUMAB-ATTO | 40MG/0.8ML | Injection |
| AMJEVITA | — | 80MG/0.8ML | Injection |
| AMJEVITA | — | 20MG/0.2ML | Injection |
| AMJEVITA | — | 40MG/0.8ML | Injection |
| AMJEVITA | — | 10MG/0.2ML | Injection |
| AMJEVITA | — | 40MG/0.4ML | Injection |
| AMJEVITA | — | 40MG/0.4ML | Injection |
| AMJEVITA | — | 80MG/0.8ML | Injection |
9 products